These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 18772035)

  • 1. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
    Marek GJ
    Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of the dopaminergic system as a key component to the understanding of depression.
    Yadid G; Friedman A
    Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic approaches in the development of novel antipsychotics.
    Jones CA; McCreary AC
    Neuropharmacology; 2008 Nov; 55(6):1056-65. PubMed ID: 18621404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin/dopamine interaction in memory formation.
    González-Burgos I; Feria-Velasco A
    Prog Brain Res; 2008; 172():603-23. PubMed ID: 18772052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin/dopamine interaction in learning.
    Olvera-Cortés ME; Anguiano-Rodríguez P; López-Vázquez MA; Alfaro JM
    Prog Brain Res; 2008; 172():567-602. PubMed ID: 18772051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
    Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin-dopamine interaction as a focus of novel antidepressant drugs.
    Esposito E
    Curr Drug Targets; 2006 Feb; 7(2):177-85. PubMed ID: 16475959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias.
    Carta M; Carlsson T; Muñoz A; Kirik D; Björklund A
    Prog Brain Res; 2008; 172():465-78. PubMed ID: 18772046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.